|
⚲
|
| Keyboard |
| Gregg Beloff | |
|---|---|
| Firm | |
| Address | 900 Third Avenue 33rd Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| SG Dan Holdings LLC | 021-323355 | Director | 14.1 M of 14.1 M |
||
| Centrexion Therapeutics Corp | 021-302145 | Executive Officer | 69.6 M of 69.6 M |
||
| Neurovance Inc | 021-277876 | Executive Officer | 0.6 M of 0.6 M |
||
| Centrexion Therapeutics Corp | 021-277676 | Executive Officer | 16.6 M of 16.6 M |
||
| Cerulean Pharma Inc | 021-272672 | Executive Officer | 0.0 M of 0.0 M |
||
| Centrexion Therapeutics Corp | 021-265466 | Executive Officer | 11.2 M | ||
| Centrexion Therapeutics Corp | 021-261501 | Executive Officer | 6.9 M | ||
| Centrexion Therapeutics Corp | 021-259218 | Executive Officer | 10.5 M | ||
| Neurovance Inc | 021-258396 | Executive Officer | 7.5 M of 16.0 M |
||
| Spring Bank Pharmaceuticals Inc | 021-211174 | Executive Officer | 6.3 M of 6.3 M |
||
| Related People Network |
|---|
| Network #376 at Cerulean Pharma Inc — files alongside 11 co-filers |